Related Experiment Video
Updated: Jul 30, 2025

In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
Artificial intelligence in cardiovascular prevention: new ways will open new doors
Michele Ciccarelli1, Francesco Giallauria2, Albino Carrizzo1,3
1Department of Medicine, Surgery and Dentistry, University of Salerno, Baronissi, Italy.
Abstract:
Prevention and effective treatment of cardiovascular disease are progressive issues that grow in tandem with the average age of the world population. Over recent decades, the potential role of artificial intelligence in cardiovascular medicine has been increasingly recognized because of the incredible amount of real-world data (RWD) regarding patient health status and healthcare delivery that can be collated from a variety of sources wherein patient information is routinely collected, including patient registries, clinical case reports, reimbursement claims and billing reports, medical devices, and electronic health records. Like any other (health) data, RWD can be analysed in accordance with high-quality research methods, and its analysis can deliver valuable patient-centric insights complementing the information obtained from conventional clinical trials. Artificial intelligence application on RWD has the potential to detect a patient's health trajectory leading to personalized medicine and tailored treatment. This article reviews the benefits of artificial intelligence in cardiovascular prevention and management, focusing on diagnostic and therapeutic improvements without neglecting the limitations of this new scientific approach.
Related Concept Videos
Coronary Artery Disease IV: Preventive Measures
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Pre-Procedural Guidelines for Assessing Blood Pressure
Atherosclerosis III: Management
Coronary Artery Disease V: Interprofessional Care
Cardiomyopathy V: Interprofessional Care

